Objective: This study aims to investigate the effects of CDKN2A (p16 INK4A /p14 ARF ) overexpression on the proliferation and migration of human melanoma A375 cells. Methods: Melanoma tissues and pigmented nevi tissues were collected. Human melanoma A375 cells were transfected by CDKN2A (p16 INK4A ) and CDKN2A (p14 ARF ) over-expressing vectors and then assigned into blank, negative control (NC), p16
Introduction
As one of the most deadly cancers in humans, melanoma is resistant to standard treatment at advanced stages and exhibits a high degree of heterogeneity [1] . Ultraviolet radiation (UVR) is the major environmental pathogenic factor of skin tumor development, and ultraviolet B (UVB) exposure plays an important role in the formation of cutaneous melanoma (CM) [2] . The incidence of melanoma accounted for approximately 4% of all skin tumors, whereas the rate of all skin cancer-related deaths was as high as 80% [3, 4] . The incidence of malignant melanoma is significantly increasing worldwide [5] . Currently, the clinical treatment for melanoma is surgical excision, which exhibited superior efficiency in melanoma without metastasis compared with melanoma with metastasis [6] . Also, adoptive cell immunotherapy provides a new option in treating melanoma, showing durable and effective antitumor effect [7] . However, Due to the high resistance of metastasis melanoma to most standard treatments, it's of great significance to explore more novel and effective therapies for melanoma with high metastatic potential [8, 9] . Given further molecular biology studies, gene therapy for tumors has significantly advanced. Tumor suppressor genes play an important role in the development and progression of tumors, providing an important strategy for tumor treatment.
Mutations in CDKN2A and CDK4 contribute to the susceptibility of approximately 40% of high-density CM families [10] . CDKN2A, a gene located in the 9p21 region of chromosome, codes for two proteins: p16 INK4A and p14 ARF [11, 12] . p16 INK4A regulates the cell cycle through the inhibition of CDK4 and CDK6 by cyclin D1 (CCND1), and its inactivation results in the hyperphosphorylation of RB1 with unlimited cell cycle progression [13] . Hypermethylation of p16 INK4A is the most relevant factor in the promotion of melanoma cell growth induced by cadmium and suppression of the cell apoptosis pathway [14] . In addition, p14
ARF inhibits the degradation of the cell-cycle regulator p53 by forming a stable complex with Mdm2 in the nucleus [15] . Recently, data showed that carriers of CDKN2A mutations have increased risks of non-melanoma cancers [16] , highlighting the importance of CDKN2A mutation screening as a clinical test of melanoma families [17] . Although the role of the CDKN2A mutation in melanoma was well established, the exact function of p16 INK4A and p14 ARF on cell proliferation, migration and invasion of melanoma is worthy further investigation to better understand the underlying molecular mechanism in melanoma. Therefore, the current study was conducted with the aim of investigating the effects of CDKN2A (p16 INK4A ) and CDKN2A (p14 ARF ) over-expression on the proliferation and migration of melanoma A375 cells.
Material and Methods

Ethical statement
This study was approved by the Ethnic Commitment of Peking Union Medical College Hospital. All patients signed written informed consent forms, and all experiments involving animals were conducted in accordance with research policies on the use of experimental animals.
Collection of tissue specimens
Between January 2013 and June 2015, a total of 64 patients with melanoma who underwent surgical resection were selected from the Department of Surgery of Peking Union Medical College Hospital. All patients did not receive chemotherapy or radiotherapy before surgery. Among these patients, there were 35 males and 29 females with a mean age of 53.9 ± 11.5 years. Twenty-seven patients had lymph node metastasis and 37 patients had no lymph node metastasis. Based on the criteria on TNM staging proposed by the American Joint Committee on Cancer (AJCC) in 2010, there were 39 cases of I/II stage and 25 cases of III/IV stage [18] . According to the Clark pathological grading, there were 29 cases of grade I/II, 21 cases of grade III and 14 cases of grade IV/V. The lesion sites were distributed in skin (25 cases), limbs (24 cases) and mucous membrane (15 cases). In addition, 76 patients with pigmented nevi were selected as the control group, including 41 males and 35 females with a mean age of 57.3 ± 9.4 years. All specimens were stored in a -80°C refrigerator after treatment with liquid nitrogen. The specimens were divided into two parts. One part was used for quantitative real time polymerase chain reaction (qRT-PCR), and another part was subject to immunohistochemistry after fixation with 10% formaldehyde and paraffin embedding.
Cell culture
Human melanoma A375 cells purchased from American Type Culture Collection were cultured in RPMI-1640 medium (Invitrogen, Gaitherburg, MD, USA) containing 10% fetal bovine serum (FBS) at an incubator with 95% humidity (5% CO 2 , 37°C). Cultured monolayer cells were passaged when the adherence INK4A cDNA and p14 ARF cDNA were inserted into pAdCMV shuttle plasmid (Stratagene, CA, USA), which together with adenovirus vector pJM17 (Microbix Biosystems, Toronto, Canada) were used to co-transfect 293 cells with Lipofectin reagent (Gibco, Grand Island, NY, USA). Through the homologous recombination of two plasmids, the target genes (Ad-p16
INK4A and Ad-p14 ARF ) were transferred into the adenovirus genome. Thus, Ad-p16
INK4A and Ad-p14 ARF recombinant adenovirus were produced. The control virus Ad-LacZ was constructed in the same manner. The 293 cells were cultured in a 96-well plate with serum-freed medium diluted virus solution for 24 h followed by the addition of 100 μL complete culture medium for 10 d. Then, virus titer was calculated by Karber method using following formula: virus titer (T) = 10
, where d = log 10 dilution, and s = summarize of positive rate. Further experiments were conducted using a multiplicity of infection (MOI) = 20.
Quantitative real-time polymerase chain reaction (qRT-PCR)
Extraction and reverse transcription of total RNA: frozen tissues (50 mg) or A375 cells transfected for 48 h were collected, and total RNA was extracted using Trizol Reagent kit (Invitrogen, Carlsbad, CA, USA). The spectrophotometer was used to detect 260/280 absorbance (≥ 1.8 indicated a pure RNA), and the extracted RNA was preserved at -80°C for future use. The Reverse Transcription System Kit (Promega, Madison, WI, USA) was applied to synthesize cDNA. Total RNA (1 μg) was placed into the microcentrifuge tube. Then, 4.0 μL of 25 mM MgCl 2, 2.0 μL of 10 × Buffer, 2.0 μL of 10 mM dNTP, 0.5 μL of Recombinant Rnasin Ribonuclease Inhibitor, 15 μL of AMV Reverse Transcriptase, 0.5 μg of Oligo(dT) 15 Primer and water containing no RNA enzyme were added until the volume of the reaction system was 20 μL. The reverse transcription conditions were 42°C for 60 min, 95°C for 5 min and 5°C for 5 min. The product was stored at 20°C for qRT-PCR amplification.
qRT-PCR reaction: specific primers were used to amplify the specific gene. The amplification was conducted based on following conditions: pre-degeneration at 95°C for 10 min, degeneration at 95°C for 10 s, annealing at 60°C for 20 s and extension at 72°C for 30 s for a total of 35 cycles. Primers for qRT-PCR were CDKN2A (p16 INK4A ) (upstream: 5'•GCCCTGGAGGCGGCGAGA•3'; downstream: 5'-CGACCGTAACTATTCGGTGCGTTGG-3') and CDKN2A (p14 ARF ) (upstream: 5'•GCCCTGGAGGCGGCGAGA•3'; downstream: 5'-TGCCCTAGACGCTGGCTCCTCA-3'). β-actin was used as the internal reference. The upstream sequence was 5'•AAGAGAGGC ATCCTCACCT•3', and the downstream sequence was 5'•TACATGGCTGGGGTGTTGAA•3'. All primers were synthesized by Shanghai Gene Pharma Co., Ltd, Shanghai, China. The 2 -ΔΔCt method was used for results analysis. The formula was ΔΔCT = ΔCt experimental group -ΔCt control group , ΔCt = Ct target gene -Ct internal reference. Ct was the number of amplification cycles when the optical density (OD) reached the set threshold value. All experiments were conducted thrice.
Western blotting
Frozen tissues (50 mg) or transfected A375 cells were added to lysis buffer (Beyotime Biotechnology, Shanghai, China) to extract total protein. Total protein was placed on ice for 30 min and centrifuged at 4°C (12000 rpm, 10 min). Then, 50 μg total protein underwent sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) using a 12% gel. Then, the protein was transferred to PVDF membrane (Millipore, USA) and blocked for one hour at 37°C using 5% skimmed milk power. Subsequently, p16
INK4a and p14 ARF mouse anti-human and β-actin monoclonal antibodies (Abcam, Cambridge, MA, USA) were added for culture at 4°C overnight. After washing with TBST thrice (10 min each time), total protein was cultured at room temperature for one hour with the addition of horseradish peroxidase-labeled rabbit anti-mouse secondary antibodies (Abcam, Cambridge, MA, USA). Then, TBST washing was conducted again using the aforementioned protocol. Chemiluminescence, photographing and photographic fixing were performed. Bai 
The relative expression of protein was expressed as the gray value ratio of the target band over the internal reference band.
Cell count kit-8 (CCK-8)
Transfected A375 cells were inoculated in a 96-well plate, and the cell number in each well at 0, 24, 48, 72 and 96 h were recorded. After the culture medium were removed, 100 μL of fresh culture solution containing 10 μL CCK-8 reagent (Beyotime Biotechnology, Shanghai, China) was added. Then, the plate was placed in the refrigerator for 2 h. The optical density (OD) was measured at 450 nm wavelength using a micro-plate reader (Bio-Rad, USA). All experiments were performed in 6 duplicated wells.
Flow cytometry (FCM)
After 48 h of transfection, A375 cells were collected, fixed with 75% absolute alcohol pre-cooled in -20°C and stored at 4°C overnight. After centrifugation, cells were washed in PBS twice to remove the fixer followed by the addition of RNaseA and incubation in the water bath for 30 min in the dark. Propidium iodide (PI) was used for staining, and FCM was applied to detect cell cycle and count the ratio of cells in G0/ G1, S and G2/M stages by recording the red fluorescence. Experiments were conducted thrice.
AnnexinV/PI double-staining method to detect cell apoptosis: after transfection for 48 h, RASFs cells were collected and adjusted to a cell density of 1 × 10 6 /ml. Then, 0.5 mL cell suspension and 1.25 μL AnnexinV-FITC (Jiangsu KeyGEN BioTECH Corp., Ltd) were added into the centrifuge tube for a 15 min reaction followed by centrifugation at 1000 rpm for 5 min. Then, the supernatant was discarded, and cells were suspended with 0.5 mL pre-cold binding buffer. PI (10 μL) was added for cell staining, and FCM (BD Biosciences, San Jose, USA) was applied for cell analysis after adding 10 μL PI. In the scatter diagram, the healthy living cells were in the left lower quadrant. In addition the early apoptotic cells were in the lower right quadrant, and the late necrotic and apoptotic cells were in the upper right quadrant. Apoptotic rate = percentage of early apoptotic cells + percentage of late apoptotic cells.
Transwell assay
Migration assay: after 48 h of transfection, cells were inoculated into the upper Transwell chamber (Corning Incorporated, USA) with serum-free medium, and 10% FBS medium was added into the lower chamber. After culture in an incubator with 5% CO 2 at 37°C for 24 h, a cotton swab was used to remove cells that failed to penetrate the upper chamber. Then, samples were fixed in 2% paraformaldehyde for 20 min and stained with 1% crystal violet staining solution for 10 min. After three PBS washes, the cells were observed under a high-power microscope, photographed and counted. Six randomized fields were chosen from each sample, and the average value was considered as an indicator for cell migration.
Invasion assay: after 72 h of transfection, cells were inoculated into the upper Transwell chamber (Corning Incorporated, USA) containing Matrigel (BD Biosciences, San Jose, USA) using serum-free medium, and 10% FBS medium was added to the lower chamber. Matrigel was diluted with serum-free medium at a proportion of 1:3 after dissolution at 4°C and then added into the upper chamber. The cells were cultured in a 37°C incubator with 5% CO 2 for 24 h, and then the number of cells that penetrated the lower chamber was determined. The counting method was the same as that used in the migration assay.
Establishment of subcutaneous xenograft in nude mice
Male BALB/c mice aged 6 to 8 weeks that weighted 18 to 20 g (Slac laboratory animal, Shanghai, China) were fed for one week. A cell suspension (2 × 10 6 ) of cells in the logarithmic growth phase from each group was inoculated into nude mice subcutaneously in the right hind limb. Each group had eight mice. The volume of transplanted tumors was measured every three days using the following formula: Volume = 1/2ab 2 ; a, maximum width; b, minimum width.
Statistical analysis
All data analysis was conducted using SPSS 21.0 (SPSS Inc., Chicago, IL, USA). Measurement data were presented as the mean ± standard deviation (SD). Enumeration data were compared using χ 2 test, and measurement data were compared using t-test. P < 0.05 was considered statistically significant. ) mRNA and protein expression were significantly decreased in melanoma tissues (all P < 0.05) (Fig. 1) ) protein expression was closely associated with lymph node metastasis, TNM staging and Clark grade (all P < 0.05) but not correlated with the age, gender and lesion site of melanoma patients (all P > 0.05).
Successful transfection of A375 cells
The titer of recombinant adenovirus was 2.5 × 10 10 U/ml as confirmed using the Karber method. Total RNA was extracted from transfected cells, and gel electrophoresis was conducted after the target genes were amplified by qRT-PCR. The results demonstrated that no target band was observed in the blank and NC groups after the amplification of CDKN2A (p16 INK4A ) and CDKN2A (p14 ARF ), but 580-bp and 730-bp bands were noted both in the p16 INK4A group and in the p14 ARF group ( Fig. 2A and 2B ). Consistent with qRT-PCR, Western (Fig. 2C) .
Effects of CDKN2A (p16 INK4A ) and CDKN2A (p14 ARF ) on A375 cell proliferation CCK-8 assay results indicated that the cells in four groups all proliferated with the passage of time. No significant difference was observed between the blank group and the NC group at all time points (all P > 0.05). Compared with the blank group, the cell proliferation rates in the p16 INK4A and p14 ARF groups were reduced 48 h after transfection (all P < 0.05). The inhibitory effect on cell growth was gradually increased over time. Seventy-two h after transfection, the inhibitory effect in the p16
INK4A group was significantly enhanced compared with the p14 ARF group (all P < 0.05) (Fig. 3) . These results suggest that high CDKN2A (p16 INK4A ) and CDKN2A (p14 ARF ) expression could inhibit the proliferation of A375 cells. (Table 2 ) demonstrated that the blank and NC groups had no significant differences in cell cycle and apoptotic rate (all P > 0.05). Compared with the blank group, the p16
INK4A and p14
ARF groups exhibited increased cells in the G0/G1 phase and an elevated apoptotic rate. The apoptotic rate in the p16 INK4A group was significantly increased compared with the p14 ARF group (all P < 0.05). These results showed that high CDKN2A (p16 INK4A ) and CDKN2A (p14 ARF ) expression inhibits the transformation of A375 cells from the G0/G1 to S phase and promotes cell apoptosis. INK4A ) and CDKN2A (p14 ARF ) on A375 cell migration and invasion Transwell migration and invasion assays revealed that the number of migratory cells in the blank and NC groups was 97.76 ± 8.56 and 89.63 ± 7.21, respectively, and the number of invasive cells was 85.23 ± 9.83 and 83.96 ± 11.56, respectively. These results reveal no significant difference in migratory and invasive cell numbers between the two groups (all P > 0.05). In the p16
Effects of CDKN2A (p16
INK4A and p14 ARF groups, the number of migratory cells was 41.46 ± 10.25 and 5.54 ± 67.73, respectively, and the number of invasive cells was 31.65 ± 9.36 and 56.73 ± 5.54, respectively. The number of migratory and invasive cells was significantly reduced in the p16 INK4A and p14 ARF groups compared with the blank group (all P < 0.05). Compared with the p14 ARF group, the number of migratory and invasive cells in the p16 INK4A group was significantly down-regulated (all P > 0.05) (Fig. 4) ARF groups. Note: *, P < 0.05 compared with the blank group; #, P < 0.05 compared with the p14 ARF group; NC, negative control. 
